Showing results (1-10 of 102) with videos related to
Sort By:
Pageof 11
Hormone Research in Paediatrics|December 1, 2021
Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of ObesityMojca Jensterle, Andrej JanežDrugs|May 9, 2026
Incretin-Based Anti-obesity Medications in Polycystic Ovary Syndrome: The Evidence MapMojca Jensterle, Andrej JanezInternational Journal of Molecular Sciences|March 13, 2025
Long-Term IGF-1 Maintenance in the Upper-Normal Range Has Beneficial Effect on Low-Grade Inflammation Marker in Adults with Growth Hormone DeficiencyAna Klinc, Andrej Janež, Mojca JensterleMetabolic Syndrome and Related Disorders|October 25, 2017
Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Prevented Weight Regain in Obese Women with Polycystic Ovary Syndrome Previously Treated with Liraglutide: A Pilot Randomized StudySimona Ferjan, Andrej Janez, Mojca JensterleBiomedicines|August 26, 2022
Therapeutic Potential of Glucagon-like Peptide-1 Agonists in Polycystic Ovary Syndrome: From Current Clinical Evidence to Future PerspectivesMojca Jensterle, Rok Herman, Andrej JanežMedicina (Kaunas, Lithuania)|September 27, 2025
Impact of Incretin-Based Therapy on Skeletal Muscle HealthAndrijana Koceva, Andrej Janež, Mojca JensterleMedicina (Kaunas, Lithuania)|May 28, 2025
The Impact of Hydration on Metabolic Outcomes: From Arginine-Vasopressin Signaling to Clinical ImplicationsAndrijana Koceva, Andrej Janež, Mojca JensterleBest Practice & Research. Clinical Endocrinology & Metabolism|September 27, 2025
Preconception use of GLP-1 and GLP-1/GIP receptor agonists for obesity treatmentAndrijana Koceva, Andrej Janež, Mojca JensterleThe Journal of Clinical Endocrinology and Metabolism|May 15, 2014
Phosphodiesterase 4 inhibition as a potential new therapeutic target in obese women with polycystic ovary syndromeMojca Jensterle, Tomaz Kocjan, Andrej JanezEndocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 18, 2017
DPP4 INHIBITOR SITAGLIPTIN AS A POTENTIAL TREATMENT OPTION IN METFORMIN-INTOLERANT OBESE WOMEN WITH POLYCYSTIC OVARY SYNDROME: A PILOT RANDOMIZED STUDYSimona Ferjan, Andrej Janez, Mojca JensterlePageof 11